Literature DB >> 27328745

Direct modulation of TRPM4 and TRPM3 channels by the phospholipase C inhibitor U73122.

Michael G Leitner1, Niklas Michel1, Marc Behrendt1, Marlen Dierich1, Sandeep Dembla1, Bettina U Wilke1, Maik Konrad1, Moritz Lindner1,2, Johannes Oberwinkler1, Dominik Oliver1.   

Abstract

BACKGROUND AND
PURPOSE: Signalling through phospholipase C (PLC) controls many cellular processes. Much information on the relevance of this important pathway has been derived from pharmacological inhibition of the enzymatic activity of PLC. We found that the most frequently employed PLC inhibitor, U73122, activates endogenous ionic currents in widely used cell lines. Given the extensive use of U73122 in research, we set out to identify these U73122-sensitive ion channels. EXPERIMENTAL APPROACH: We performed detailed biophysical analysis of the U73122-induced currents in frequently used cell lines. KEY
RESULTS: At concentrations required to inhibit PLC, U73122 modulated the activity of transient receptor potential melastatin (TRPM) channels through covalent modification. U73122 was shown to be a potent agonist of ubiquitously expressed TRPM4 channels and activated endogenous TRPM4 channels in CHO cells independently of PLC and of the downstream second messengers PI(4,5)P2 and Ca(2+) . U73122 also potentiated Ca(2) (+) -dependent TRPM4 currents in human Jurkat T-cells, endogenous TRPM4 in HEK293T cells and recombinant human TRPM4. In contrast to TRPM4, TRPM3 channels were inhibited whereas the closely related TRPM5 channels were insensitive to U73122, showing that U73122 exhibits high specificity within the TRPM channel family. CONCLUSIONS AND IMPLICATIONS: Given the widespread expression of TRPM4 and TRPM3 channels, these actions of U73122 must be considered when interpreting its effects on cell function. U73122 may also be useful for identifying and characterizing TRPM channels in native tissue, thus facilitating the analysis of their physiology.
© 2016 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27328745      PMCID: PMC4959952          DOI: 10.1111/bph.13538

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  70 in total

1.  Two compounds commonly used for phospholipase C inhibition activate the nuclear estrogen receptors.

Authors:  B Cenni; D Picard
Journal:  Biochem Biophys Res Commun       Date:  1999-08-02       Impact factor: 3.575

2.  The putative phospholipase C inhibitor U73122 and its negative control, U73343, elicit unexpected effects on the rabbit parietal cell.

Authors:  Y Muto; T Nagao; T Urushidani
Journal:  J Pharmacol Exp Ther       Date:  1997-09       Impact factor: 4.030

3.  Transient receptor potential M3 channels are ionotropic steroid receptors in pancreatic beta cells.

Authors:  Thomas F J Wagner; Sabine Loch; Sachar Lambert; Isabelle Straub; Stefanie Mannebach; Ilka Mathar; Martina Düfer; Annette Lis; Veit Flockerzi; Stephan E Philipp; Johannes Oberwinkler
Journal:  Nat Cell Biol       Date:  2008-11-02       Impact factor: 28.824

4.  Experimental design and analysis and their reporting: new guidance for publication in BJP.

Authors:  Michael J Curtis; Richard A Bond; Domenico Spina; Amrita Ahluwalia; Stephen P A Alexander; Mark A Giembycz; Annette Gilchrist; Daniel Hoyer; Paul A Insel; Angelo A Izzo; Andrew J Lawrence; David J MacEwan; Lawrence D F Moon; Sue Wonnacott; Arthur H Weston; John C McGrath
Journal:  Br J Pharmacol       Date:  2015-07       Impact factor: 8.739

5.  TRPM4, a Ca2+-activated nonselective cation channel in mouse sino-atrial node cells.

Authors:  Marie Demion; Patrick Bois; Pierre Launay; Romain Guinamard
Journal:  Cardiovasc Res       Date:  2006-11-22       Impact factor: 10.787

6.  The interaction of U-73122 with the histamine H1 receptor: implications for the use of U-73122 in defining H1 receptor-coupled signalling pathways.

Authors:  S A Hughes; W J Gibson; J M Young
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2000-12       Impact factor: 3.000

Review 7.  Phosphoinositide dynamics in the postsynaptic membrane compartment: Mechanisms and experimental approach.

Authors:  Michael G Leitner; Christian R Halaszovich; Olga Ivanova; Dominik Oliver
Journal:  Eur J Cell Biol       Date:  2015-06-03       Impact factor: 4.492

8.  Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines.

Authors:  Lindsey J Macpherson; Adrienne E Dubin; Michael J Evans; Felix Marr; Peter G Schultz; Benjamin F Cravatt; Ardem Patapoutian
Journal:  Nature       Date:  2007-01-21       Impact factor: 49.962

9.  Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils.

Authors:  J E Bleasdale; N R Thakur; R S Gremban; G L Bundy; F A Fitzpatrick; R J Smith; S Bunting
Journal:  J Pharmacol Exp Ther       Date:  1990-11       Impact factor: 4.030

10.  1-[6-[[(17beta)-3-methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione (U73122) selectively inhibits Kir3 and BK channels in a phospholipase C-independent fashion.

Authors:  Angelika Klose; Tobias Huth; Christian Alzheimer
Journal:  Mol Pharmacol       Date:  2008-08-05       Impact factor: 4.436

View more
  18 in total

1.  TRPM4 and TRPM5 are both required for normal signaling in taste receptor cells.

Authors:  Debarghya Dutta Banik; Laura E Martin; Marc Freichel; Ann-Marie Torregrossa; Kathryn F Medler
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-08       Impact factor: 11.205

Review 2.  TRPM3_miR-204: a complex locus for eye development and disease.

Authors:  Alan Shiels
Journal:  Hum Genomics       Date:  2020-02-18       Impact factor: 4.639

Review 3.  Calcium signals that determine vascular resistance.

Authors:  Matteo Ottolini; Kwangseok Hong; Swapnil K Sonkusare
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2019-03-18

4.  Direct modulation of TRPM4 and TRPM3 channels by the phospholipase C inhibitor U73122.

Authors:  Michael G Leitner; Niklas Michel; Marc Behrendt; Marlen Dierich; Sandeep Dembla; Bettina U Wilke; Maik Konrad; Moritz Lindner; Johannes Oberwinkler; Dominik Oliver
Journal:  Br J Pharmacol       Date:  2016-07-18       Impact factor: 8.739

5.  The phospholipase C inhibitor U73122 is a potent agonist of the polymodal transient receptor potential ankyrin type 1 (TRPA1) receptor channel.

Authors:  Cristian Neacsu; Susanne K Sauer; Peter W Reeh; Alexandru Babes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-09-03       Impact factor: 3.000

6.  Endoplasmic reticulum (ER) Ca2+-channel activity contributes to ER stress and cone death in cyclic nucleotide-gated channel deficiency.

Authors:  Michael R Butler; Hongwei Ma; Fan Yang; Joshua Belcher; Yun-Zheng Le; Katsuhiko Mikoshiba; Martin Biel; Stylianos Michalakis; Anthony Iuso; David Križaj; Xi-Qin Ding
Journal:  J Biol Chem       Date:  2017-05-11       Impact factor: 5.157

7.  β3 Adrenoceptor-induced cholinergic inhibition in human and rat urinary bladders involves the exchange protein directly activated by cyclic AMP 1 favoring adenosine release.

Authors:  Isabel Silva; M Teresa Magalhães-Cardoso; Fátima Ferreirinha; Sílvia Moreira; Ana Filipa Costa; Diogo Silva; Cátia Vieira; Miguel Silva-Ramos; Paulo Correia-de-Sá
Journal:  Br J Pharmacol       Date:  2020-02-06       Impact factor: 8.739

8.  Regulator of G-protein signaling Gβ5-R7 is a crucial activator of muscarinic M3 receptor-stimulated insulin secretion.

Authors:  Qiang Wang; Alexey N Pronin; Konstantin Levay; Joana Almaca; Alessia Fornoni; Alejandro Caicedo; Vladlen Z Slepak
Journal:  FASEB J       Date:  2017-07-07       Impact factor: 5.191

9.  Anti-nociceptive action of peripheral mu-opioid receptors by G-beta-gamma protein-mediated inhibition of TRPM3 channels.

Authors:  Sandeep Dembla; Marc Behrendt; Florian Mohr; Christian Goecke; Julia Sondermann; Franziska M Schneider; Marlene Schmidt; Julia Stab; Raissa Enzeroth; Michael G Leitner; Paulina Nuñez-Badinez; Jochen Schwenk; Bernd Nürnberg; Alejandro Cohen; Stephan E Philipp; Wolfgang Greffrath; Moritz Bünemann; Dominik Oliver; Eleonora Zakharian; Manuela Schmidt; Johannes Oberwinkler
Journal:  Elife       Date:  2017-08-15       Impact factor: 8.140

10.  Inverse Modulation of Neuronal Kv12.1 and Kv11.1 Channels by 4-Aminopyridine and NS1643.

Authors:  Marlen Dierich; Saskia Evers; Bettina U Wilke; Michael G Leitner
Journal:  Front Mol Neurosci       Date:  2018-01-30       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.